Evidence map›Paper›PMID 18477694›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Atomic interactions of neonicotinoid agonists with AChBP: molecular recognition of the distinctive electronegative pharmacophore.

Todd T Talley, Michal Harel, Ryan E Hibbs, Zoran Radic, Motohiro Tomizawa, John E Casida, Palmer Taylor

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 172 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Investigations on the E/Z-isomerism of neonicotinoids.Journal of computer-aided molecular design · 2021
    Article
  10. Studies onJournal of pesticide science · 2017
    Article
  11. Article
  12. Article
  13. Insight into the Binding Mode of Agonists of the Nicotinic Acetylcholine Receptor from Calculated Electron Densities.Chemphyschem : a European journal of chemical physics and physical chemistry · 2015
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Todd T TalleyDepartment of Pharmacology, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA 99093-0657, USA.
Michal Harel
Ryan E Hibbs
Zoran Radic
Motohiro Tomizawa
John E Casida
Palmer Taylor
University of Montana · USUniversity of California, Berkeley · USWeizmann Institute of Science · IL

Funding

KINETICS OF DRUG MACROMOLECULE COMPLEX FORMATIONR37GM018360 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAYLOR, PALMER WILLIAM · 1999 to 2008
$5.7M
CHOLINERGIC INSECTICIDE TOXICOLOGYR01ES008424 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CASIDA, JOHN E · 1998 to 2006
$1.5M
Alpha Neurotoxin Probes of Nicotinic AChRF32NS043063 · NINDS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI TALLEY, TODD T · 2002 to 2004
$134k
NIEHS NIH HHS R01 ES008424NIEHS NIH HHS R01 ES08424NIGMS NIH HHS R37 GM018360NIGMS NIH HHS R37-GM18360NINDS NIH HHS F32 NS043063NINDS NIH HHS UO1-NS05846
6 · The paper itself

Abstract

Acetylcholine-binding proteins (AChBPs) from mollusks are suitable structural and functional surrogates of the nicotinic acetylcholine receptors when combined with transmembrane spans of the nicotinic receptor. These proteins assemble as a pentamer with identical ACh binding sites at the subunit interfaces and show ligand specificities resembling those of the nicotinic receptor for agonists and antagonists. A subset of ligands, termed the neonicotinoids, exhibit specificity for insect nicotinic receptors and selective toxicity as insecticides. AChBPs are of neither mammalian nor insect origin and exhibit a distinctive pattern of selectivity for the neonicotinoid ligands. We define here the binding orientation and determinants of differential molecular recognition for the neonicotinoids and classical nicotinoids by estimates of kinetic and equilibrium binding parameters and crystallographic analysis. Neonicotinoid complex formation is rapid and accompanied by quenching of the AChBP tryptophan fluorescence. Comparisons of the neonicotinoids imidacloprid and thiacloprid in the binding site from Aplysia californica AChBP at 2.48 and 1.94 A in resolution reveal a single conformation of the bound ligands with four of the five sites occupied in the pentameric crystal structure. The neonicotinoid electronegative pharmacophore is nestled in an inverted direction compared with the nicotinoid cationic functionality at the subunit interfacial binding pocket. Characteristic of several agonists, loop C largely envelops the ligand, positioning aromatic side chains to interact optimally with conjugated and hydrophobic regions of the neonicotinoid. This template defines the association of interacting amino acids and their energetic contributions to the distinctive interactions of neonicotinoids.

Indexed as

AplysiaAnimalsBridged Bicyclo Compounds, HeterocyclicCrystallography, X-RayImidazolesImidazolinesKineticsLigandsNeonicotinoidsNicotineNicotinic AgonistsNitro CompoundsProtein ConformationPyridinesReceptors, NicotinicThiazinesBridged Bicyclo Compounds, HeterocyclicdesnitroimidaclopridepibatidineimidaclopridImidazolesImidazolinesLigandsNeonicotinoidsNicotineNicotinic AgonistsNitro CompoundsPyridinesReceptors, NicotinicthiaclopridThiazines

Identifiers

PMID18477694
PMCPMC2396707
OpenAlexW2010502341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.